Home  Feedback  Career  Sitemap  Contact Us
Market Buzz
Corporate Info
Market Analysis
Corporate Action
Other Markets
Bliss GVS Pharma ( 20-Feb-19 )
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 25 February 2019.
Cipla ( 20-Feb-19 )
Cipla has allotted 4,576 equity shares under Employee Stock Option Scheme. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 1,61,13,98,096 comprising of 80,56,99,048 equity shares of face value Rs.2/- each.
Linde India ( 20-Feb-19 )
Linde India announced that the Board of Directors of the Company at its meeting held on 19 February 2019, has recommended a Interim dividend of Rs.1.5 per share(i.e.15%), subject to the approval of the shareholders.
Lak. Prec. Screw ( 20-Feb-19 )
Lakshmi Precision Screws announced that five Resolution Applicants have evinced interest for the revival of the company under CIRP, till last date of submission of resolution plans. The Committee of Creditors is in further negotiation with the prospective resolution applicants.
Vedanta ( 20-Feb-19 )
Vedanta announced that CRISIL has revised the rating for the company from CRISIL AA/ Positive/ CRISIL A1+ to CRISIL AA/ Stable / CRISIL A1+.
Jubilant Life ( 20-Feb-19 )
Jubilant Life Sciences has issued commercial paper of Rs 75 crore on 20 February 2019. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs. 175 crore.
Himatsing. Seide ( 20-Feb-19 )
Himatsingka Seide has commenced trial production at its new Greenfield Terry Towel Plant, located in Hassan, Karnataka, effective 20 February 2019. The new Terry Towel Plant will have an installed capacity of 25,000 Tonnes per Annum (TPA).
Govind Poy Oxyg ( 20-Feb-19 )
Govind Poy Oxygen announced that the Board of Directors of the Company at its meeting held on 13 February 2019 approved the appointment of Shruti Subhash Nilekani as the Company Secretary and Compliance Officer of the Company with effect from 18 February 2019.
Back Top
Source:Capital Market

Member Code : NCDEX - 00241 | MCX - 31435
SEBI Regn. Nos : BSE INB010643030 | NSE(EQ) INB230643037 | NSE(FUT) INF230643037 FOR INVESTORS GRIEVANCE : complaints@cilsecurities.com
FOR DP GRIEVANCE : grievance@cilsecurities.com
Privacy Policy  |  Disclaimer | BrokerNorms |  BSE Complaints
Useful Links :  NSE | BSE  | CDSL | MCX  | NCDEX | SEBI | RBI
Designed , Developed & Powered By C-MOTS Infotech
(ISO 9001:2015 certified)